We would love to hear your thoughts about our site and services, please take our survey here.
Yes Krone , I detected added enthusiasm in his response , although it was pointed out that this was his default response to that particular line of questioning .
However this time you could detect additional levels of excitement
Heard you barking with enthusiasm at the meeting this morning
I think thats when the dog started barking
When asked about licensing Tim made it clear the plan was to add value by completing early stage trials .
However he followed that up with " if we get a good offer at an earlier stage then we would look very carefully at that " .
Think that speaks volumes
Very Guarded however also very positive re
being best in class and patent protection and ability to extend .
Footnote - squeeky chair change out for a barking dog.
Much appreiciated Adam , I believe we will get the result that we want in the end .
Pressure and harrasment does no one any good .
The critisizm whilst in some eyes is justified I believe if the company and the directors are working towards a common goal of achieving sucssess scientifically , along with targeted diesese modification and / or cure whilst at the same time making the company stronger on the MC in the balance of time - even if we have hicupps along the way .
I believe in the direction they are going , they have been open about thier plans and and I think it will all come good in the end .
Thanks for the post - your input will be of much added value and I am sure they will be very much aware of that and take on a lot of what you say .
Cheers
Whoever is responding is spitting out the answer without actually saying so .
Q3 update .
If there was no interest the answer would have been along the lines of " we will be evaluating " The other clue is the "re- naming" . You don't say that unless there are plans in place .
Best of luck troops .
I would also recommend downloading Sareum's origional Companies Articles of Association v's the new version that was produced and formally incorporated earlier this year .
The changes should tell you everything and the direection we are heading .
Party Time
QUOTE " " , should the company decide to progress such trials ."
Is this an clouded way of saying - they don't expect to be the descision makers for and when that time arises.
Also the appointment of Consilium .
Is someone else directing them to make this business change - should this be RNS 'd ?
Otherwise very clear and plans and fiancial status laid out well .
Thanks for the feedback HBD , I just think ( as I have for ages ) we are on the cusp of
something very financially rewarding .
Cheers
Todays RNS re board appointments also stated in the last paragraph - Quote
" These changes continue the transition of the Board as an independent biopharma company post separation. GSK expects to announce further Non-Executive Director appointments shortly"
If you were a betting man I wonder what the odds would be on any of Sareum's Directors being offered a position -
Also Rothchild deal was no deal no fee basis ?
Suzy is Casper
Agreed Aber - + also note GSK split date - 18th July , consolidation exercise , GSK 's Sierra purchase , updating Saerum's AofA,
Radio silence . mmh ?
His statement says much about Valirix and our Key Personel - Cannot get much better The King's research is led by Professor Martin Ulmschneider, Professor of Computational Chemistry and the incoming Head of the Department of Chemistry who commented:
"Working together with ValiRx has been an incredible experience, and highlights the importance of finding great commercial partners that believe in translating new approaches from the laboratory towards clinical application for patient benefit. I am very excited about the journey forward with ValiRx."
https://www.lse.co.uk/DirectorsDeals.asp?shareprice=VAL&share=Valirx
https://www.lse.co.uk/DirectorsDeals.asp?shareprice=VAL&share=Valirx
Ok guys , I have looked at the RNS and it does not say 1.9 mill .
Far less .
But I initially reviewed the LSE directors dealings and this is where the figure I saw came from .
So it is either a pre dillution figure or just wrong info .
Appologies
Gerard Desler - According to the available data @ Having purchased 25000 shares at the placing it brought his total holding to 128668 as of 7th July 22 .
His previous reported holding was as of 18th February 2021 when he purchased 22000 to bring his holding to 1963875.
So on the face of it he disposed of a large quantity in the period between .
Maybe he was after a new Bentley and a nice pad in the Greek Islands or ?
Just an observation like -
RMM - Nah - your always on the ball . I dont get it ??? .
Potnak called that , hats doffed Sir